Oxford Biodynamics PLC (OBD)

Currency in GBP
0.18
-0.02(-10.00%)
Real-time Data·
Trading near 52-week Low
OBD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.180.18
52 wk Range
0.180.78
Key Statistics
Bid/Ask
0.18 / 0.21
Prev. Close
0.2
Open
0.18
Day's Range
0.18-0.18
52 wk Range
0.18-0.78
Volume
16.14K
Average Vol. (3m)
16.75M
1-Year Change
-60%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
OBD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.00
Upside
+455.56%
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

Oxford Biodynamics PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch Orion, a cloud platform, running on google cloud architecture; and EpiSwitch Explorer Array Kit platform, enabling advanced analysis of 3D regulatory control points. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

Employees
41

Compare OBD to Peers and Sector

Metrics to compare
OBD
Peers
Sector
Relationship
P/E Ratio
−0.7x−6.6x−0.5x
PEG Ratio
−0.01−0.080.00
Price / Book
7.3x1.8x2.6x
Price / LTM Sales
7.4x4.5x3.2x
Upside (Analyst Target)
-103.7%45.7%
Fair Value Upside
Unlock6.7%4.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1.00
(+455.56% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Dec 16, 2025
EPS / Forecast
-- / --
Revenue / Forecast
508K / --
EPS Revisions
Last 90 days

OBD Income Statement

FAQ

What Is the Oxford Biodynamics (OBD) Stock Price Today?

The Oxford Biodynamics stock price today is 0.18 GBP.

What Stock Exchange Does Oxford Biodynamics Trade On?

Oxford Biodynamics is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Oxford Biodynamics?

The stock symbol for Oxford Biodynamics is "OBD."

What Is the Oxford Biodynamics Market Cap?

As of today, Oxford Biodynamics market cap is 8.37M GBP.

What Is Oxford Biodynamics's Earnings Per Share (TTM)?

The Oxford Biodynamics EPS (TTM) is -0.01.

When Is the Next Oxford Biodynamics Earnings Date?

Oxford Biodynamics will release its next earnings report on Jun 23, 2026.

From a Technical Analysis Perspective, Is OBD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Oxford Biodynamics Stock Split?

Oxford Biodynamics has split 0 times.

How Many Employees Does Oxford Biodynamics Have?

Oxford Biodynamics has 41 employees.

What is the current trading status of Oxford Biodynamics (OBD)?

As of Apr 16, 2026, Oxford Biodynamics (OBD) is trading at a price of 0.18 GBP, with a previous close of 0.20 GBP. The stock has fluctuated within a day range of 0.18 GBP to 0.18 GBP, while its 52-week range spans from 0.18 GBP to 0.78 GBP.

What Is Oxford Biodynamics (OBD) Price Target According to Analysts?

The average 12-month price target for Oxford Biodynamics is 1.00 GBP, with a high estimate of 1 GBP and a low estimate of 1 GBP. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +455.56% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.